IL-33 provides protection against pneumonia-induced acute lung injury, potentially mediated through increased eosinophilia and lower neutrophil recruitment [38], while the role of IL-1α (in comparison to IL-1β) are poorly understood, but likely act through liver-dependent mechanisms [39]. The gene discussed is IL1B; the disease is pneumonia.